ORGO
Organogenesis Holdings Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth -6.7% ·
share flow -10.3% ·
net new positions -7.1%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 65 | +3 | 49.96M | $121.38M | +7 | −3 |
| Q1 2026 | 63 | -8 | 40.42M | $96.13M | +5 | −14 |
| Q4 2025 | 72 | +2 | 50.45M | $261.28M | +3 | — |
| Q3 2025 | 15 | -1 | 28.00M | $118.17M | — | −2 |
| Q2 2025 | 14 | -1 | 16.35M | $59.84M | — | −1 |
| Q1 2025 | 12 | +1 | 8.11M | $35.03M | +1 | — |
| Q4 2024 | 11 | 0 | 8.24M | $26.36M | — | — |
| Q3 2024 | 10 | 0 | 7.43M | $21.26M | — | — |
| Q2 2024 | 10 | — | 6.90M | $19.31M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 5.20M | — | $19.02M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passive) | 5.20M | — | $19.02M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passive) | 5.20M | — | $19.02M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 4.73M | — | $17.33M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 4.73M | — | $17.33M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 4.73M | — | $17.33M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 4.73M | — | $17.33M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 4.73M | — | $17.33M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 4.73M | — | $17.33M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 4.73M | — | $17.33M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passive) | 1.67M | -1.8% | $6.13M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passive) | 1.67M | -1.8% | $6.13M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | State Street Global Advisors ✦ (passive) | 1.51M | -22.3% | $5.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 803.90K | -23.0% | $2.94M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 717.07K | -19.8% | $2.62M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 717.07K | -19.8% | $2.62M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 717.07K | -19.8% | $2.62M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 613.06K | -30.7% | $2.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 613.06K | -30.7% | $2.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Wellington Management ✦ | 419.43K | +70.8% | $1.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Wellington Management ✦ | 419.43K | +70.8% | $1.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Wellington Management ✦ | 419.43K | +70.8% | $1.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 193.50K | — | $708,221 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 150.62K | -53.7% | $551,280 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Millennium Management ✦ | 138.98K | -13.7% | $508,667 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 100.78K | -57.4% | $368,851 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | Norges Bank ✦ (passive) | 64.90K | -86.5% | $237,534 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 32.89K | +13.8% | $121,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Arrowstreet Capital | $701,590 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 121 holders, 62.04M shares, $141.33M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.